CNBC·2026-02-04 07:48Group 1: UBS Performance - UBS reported a 56% year-on-year increase in fourth-quarter profit, reaching $1.2 billion, which surpassed expectations [1] - The bank announced a $3 billion share buyback plan for 2026, with intentions to exceed this target [1] Group 2: Novo Nordisk Challenges - Novo Nordisk disappointed investors by forecasting a decline in sales and profit growth for the year, leading to a more than 14% drop in its American depository shares [2] - CEO Mike Doustdar indicated that the company will face pricing headwinds in a competitive market in 2026 [2] Group 3: Novo Nordisk Long-term Outlook - Despite current challenges, Novo Nordisk expects long-term tailwinds, particularly with the recent launch of Wegovy in pill form and the approval of a higher dose of its injection by U.K. regulators [3] - The company is actively exploring potential M&A opportunities [3] Group 4: Market Trends - Major U.S. indexes experienced declines, with the S&P 500 down 0.84% and the Dow Jones Industrial Average falling 0.34% [3] - The tech-heavy Nasdaq Composite dropped 1.43%, influenced by significant losses in software stocks like ServiceNow and Salesforce, which fell nearly 7% [4] - Asian software firms also faced declines, with Japanese companies leading the losses in the region [4] Group 5: Private Credit Market - Asset firms with substantial holdings in the private credit market, such as Blue Owl, Ares Management, and KKR, saw declines, as the software industry constitutes about 20% of private loans from direct lenders [5]